Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with endometrial cancer (cancer of the lining of the uterus), at any stage (I through IV) and any grade or type
- People aged 18 years or older
- People who have been assessed as fit enough for surgery using a standard medical scoring system called the ASA classification, scoring between 1 and 3 (confirm with trial site)
- People who have undergone or are undergoing surgery for staging, tumour removal, or diagnosis, where tissue samples have been tested using specialised laboratory methods to identify the molecular profile of their cancer
- People who have given written consent to participate in the trial
Who may not be able to join:
- People whose medical records have incomplete or missing information
- People who were not treated at one of the participating trial centres, where only partial or fragmented information is available
- People whose cancer's molecular profile is unknown, unavailable, or cannot be retrieved and analysed from past records
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Francesco Fanfani, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phone: +390630133421
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease Free Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.